Hi JackTrader, I've followed this for at least five years, held a few but got out. I was first attracted to it because in days gone by I spent a year in Africa, had severe malaria, nearly killed me. Not pleasant. I have followed your fortunes and those of all the other loyal holders with interest, always hoping it would come good. I got back in a couple of weeks ago at 2.5. Seems to me that with a successful phase 3 under their belt, either a trade sale or JV will be a given, probabaly a trade sale. Only question will be what's it worth? How many emerging drugs are there at Phase 3 with what is effectively a disruptive treatment carrying a market cap of $20 million? Plenty of upside here, IMHO.
Good luck to you all, you deserve the rewards.
EMS Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held